NCT07167134View on ClinicalTrials.gov

Evolution of Hypofractionated Stereotactic Irradiation for Radio-Resistant Brain Metastases From D1-3-5 to D1-2-3

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2028

Study Completion Date

April 30, 2030

Conditions
Brain Metastases
Interventions
RADIATION

D1-3-5 radiotherapy

23.1 Gray (Gy) delivered in 3 fractions of 7.7 Gy at D1, D3, and D5

RADIATION

D1-2-3 radiotherapy

23.1 Gray (Gy) delivered in 3 fractions of 7.7 Gy at D1, D2, and D3

Trial Locations (1)

Unknown

ICANS, Strasbourg

All Listed Sponsors
lead

Centre Paul Strauss

OTHER